The firm's preliminary revenues were lower than expected and led to analyst downgrades and a drop in early trade.
Researchers sequenced seven dozen flu patients to characterize viral genetic diversity and examine viral transmission.
The bank downgraded Quidel's shares to market perform and trimmed its Q4 revenue forecast due to a mild flu season.
The test is the first of several planned CLIA-waived assays from Cepheid, and the first point-of-care test on the market to differentiate flu from RSV.
The Enigma MiniLab runs single-tube multiplex panels at the point of care, with a lower price point than other commercially available syndromic panel platforms.
The assay runs on the company's fully automated PCR-based Idylla platform and detects various strains of the flu virus and respiratory syncytial virus.
A team of Chinese researchers has found using PCR and sequencing approaches that avian flu appears to have been transmitted between two unrelated people.
At AMP's annual meeting, a researcher presented results of a study to determine the Cobas Liat Influenza A/B assay's impact on clinical decision making in the ER.
The Malaysian company received CE-IVD marking for its PCR-based tests for influenza A/B and for cholera.
The firm has added 46 influenza strains and seven respiratory syncitial virus strains to its Simplexa Flu A/B & RSV Direct kit.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.